Imodium

Loperamide Hydrochloride, the active ingredient in Imodium, is a peripheral µ‑opioid receptor agonist presented as an oral formulation for oral use. It is used to reduce the frequency and urgency of stools in adults and children with acute or chronic diarrhea, including diarrhea‑predominant irritable bowel syndrome.

GNH USA supplies Imodium as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Its supply chain supports timely delivery across EU and other markets.

Imodium (loperamide) is employed in the management of diarrheal disorders by slowing intestinal transit and enhancing fluid absorption. - Acute nonspecific diarrhea: Reduces stool frequency and urgency, helping patients regain normal bowel function. - Chronic diarrhea: Provides symptomatic relief by decreasing bowel movements in long‑term diarrheal conditions. - Irritable bowel syndrome with diarrhea (IBS‑D): Alleviates diarrheal episodes, improving quality of life for IBS‑D patients.

Loperamide may cause a range of adverse reactions, most of which are mild and self‑limiting.

Common Side Effects: - Constipation: Harder stools or reduced bowel movements. - Abdominal cramps: Mild to moderate cramping sensations. - Nausea: Feeling of sickness or urge to vomit. - Dizziness: Light‑headedness or vertigo.

Serious or Rare Side Effects: - Paralytic ileus: Severe bowel obstruction requiring medical attention. - Cardiac arrhythmias: Irregular heart rhythms, especially at high doses. - Severe allergic reaction: Rash, itching, swelling, or difficulty breathing.

Before using Imodium, consider the following precautions to ensure safe and effective therapy. - Contraindication: Do not use in patients with known hypersensitivity to loperamide. - Infection risk: Avoid in cases of bacterial dysentery or colitis caused by invasive organisms. - Liver impairment: Use with caution in severe hepatic dysfunction. - Pediatric use: Follow pediatric dosing guidelines; avoid in children under 2 years without medical advice. - Opioid interactions: Monitor for additive central opioid effects if combined with other opioid agents. - Store at ambient temperature: Keep below 25 °C, in the original packaging, protected from moisture and direct sunlight.

Loperamide can interact with other medicines, altering its effectiveness or increasing the risk of adverse events.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): May raise loperamide plasma levels, increasing toxicity risk. - P-glycoprotein inhibitors (e.g., quinidine, verapamil): Can enhance central nervous system exposure and precipitate cardiac effects.

Moderate Interactions (Monitor Closely): - Other antidiarrheals: Combined use may cause excessive constipation. - Opioid analgesics: Additive opioid effects may increase sedation or respiratory depression. - Anticholinergic agents: May worsen constipation.